These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

720 related items for PubMed ID: 12806859

  • 1. [After the early termination of the Women's Health Initiative study. New American recommendations for postmenopausal hormone therapy].
    Stjernquist M, North American Menopause Society (NAMS) Advisory Panel.
    Lakartidningen; 2003 May 15; 100(20):1790-7. PubMed ID: 12806859
    [Abstract] [Full Text] [Related]

  • 2. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
    Kuhl H, Stevenson J.
    Gynecol Endocrinol; 2006 Jun 15; 22(6):303-17. PubMed ID: 16785155
    [Abstract] [Full Text] [Related]

  • 3. Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study.
    Kang BM, Kim MR, Park HM, Yoon BK, Lee BS, Chung HW, Cho SH, Choi H, Kim JG.
    Menopause; 2006 Jun 15; 13(1):125-9. PubMed ID: 16607108
    [Abstract] [Full Text] [Related]

  • 4. [Health symptom-free women do not need preventive hormone replacement therapy. The risks outweigh the benefits; a large trial prematurely interrupted in the USA].
    von Schoultz B.
    Lakartidningen; 2002 Aug 22; 99(34):3276-8. PubMed ID: 12362844
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.
    Modena MG, Sismondi P, Mueck AO, Kuttenn F, Lignières Bd, Verhaeghe J, Foidart JM, Caufriez A, Genazzani AR, TREAT.
    Maturitas; 2005 Sep 16; 52(1):1-10. PubMed ID: 15963666
    [Abstract] [Full Text] [Related]

  • 9. Estrogen plus progestin and the risk of coronary heart disease.
    Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, Trevisan M, Black HR, Heckbert SR, Detrano R, Strickland OL, Wong ND, Crouse JR, Stein E, Cushman M, Women's Health Initiative Investigators.
    N Engl J Med; 2003 Aug 07; 349(6):523-34. PubMed ID: 12904517
    [Abstract] [Full Text] [Related]

  • 10. Impact of WHI conclusions and ACOG guidelines on clinical practice.
    Gass M.
    Int J Fertil Womens Med; 2003 Aug 07; 48(3):106-10; discussion 137-8. PubMed ID: 12839140
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The impact of the Women's Health Initiative on hormone replacement therapy in a Medicaid program.
    Hillman JJ, Zuckerman IH, Lee E.
    J Womens Health (Larchmt); 2004 Nov 07; 13(9):986-92. PubMed ID: 15665655
    [Abstract] [Full Text] [Related]

  • 13. A comparative review of the risks and benefits of hormone replacement therapy regimens.
    Warren MP.
    Am J Obstet Gynecol; 2004 Apr 07; 190(4):1141-67. PubMed ID: 15118656
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Recent epidemiological evidence relevant to the clinical management of the menopause.
    Shapiro S.
    Climacteric; 2007 Oct 07; 10 Suppl 2():2-15. PubMed ID: 17882666
    [Abstract] [Full Text] [Related]

  • 16. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
    Gurney EP, Nachtigall MJ, Nachtigall LE, Naftolin F.
    J Steroid Biochem Mol Biol; 2014 Jul 07; 142():4-11. PubMed ID: 24172877
    [Abstract] [Full Text] [Related]

  • 17. [Hormone replacement therapy and the risk of developing breast cancer].
    Merz WE.
    MMW Fortschr Med; 2004 Feb 26; 146(9):26-8, 30. PubMed ID: 15352702
    [Abstract] [Full Text] [Related]

  • 18. The Women's Health Initiative estrogen plus progestin trial: the study and how it changes our practice.
    Hendrix SL.
    J Am Osteopath Assoc; 2003 Feb 26; 103(2 Suppl 2):S3-5. PubMed ID: 12625631
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E, Canfell K.
    Am J Epidemiol; 2009 Jul 01; 170(1):24-8. PubMed ID: 19468078
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.